News Release 

Bentham's latest eBook: Frontiers in Clinical Drug Research-Alzheimer Disorders -- Vol. 8

This eBook is edited by Dr. Atta-ur-Rehman, published on March 4, 2019

Bentham Science Publishers

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer's disease research.

The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:

  • Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
  • The Therapy of Alzheimer's Disease: Towards a New Generation of Drugs
  • Could Antibiotics Be Therapeutic Agents in Alzheimer's Disease?
  • Use of Antipsychotics in Patients with Alzheimer's Disease
  • Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
  • Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease

###

About the Author: Dr. Atta-ur-Rahman

Dr. Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 253 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.

For further details, please visit: https://ebooks.benthamscience.com/book/9789811401893/

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.